yahoo_financeOriginal article
TRYNGOLZA® (olezarsen) recommended for approval in the EU by CHMP for severe hypertriglyceridemia (sHTG)
RegulatorypositiveTRYNGOLZAPositive
AI Analysis
Summary
The EMA's CHMP recommended approval of TRYNGOLZA (olezarsen) in the EU for severe hypertriglyceridemia (sHTG). The European Commission's final decision is still pending.
Outcome Details
CHMP recommended approval of TRYNGOLZA (olezarsen) in the EU for severe hypertriglyceridemia (sHTG). A CHMP positive opinion is not a final approval; European Commission decision is still pending.
Importance:7/10
Sentiment:
0.70
CHMPEUregulatorypositive opinionsevere hypertriglyceridemiasHTGolezarsenantisense
Related Companies
Read the original article
Published by yahoo_finance on October 16, 2026 10:45 AM